SCHEMBL3241269

SCHEMBL3241269

NC(=O)C1CCCCN1[C@]1(Cc2cccc(Cl)c2)C(=O)Nc2cc(Cl)ccc21

nearest known ligand 0.51

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
MDM2 Q00987 14/20 0.51
TP53 P04637 11/20 0.51
ACHE P22303 4/20 0.37
MDM4 O15151 2/20 0.36
F2 P00734 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1322973 0.97 MDM2 (0.54) MDM2TP53ACHE
SCHEMBL1322975 0.97 MDM2 (0.54) MDM2TP53ACHE
SCHEMBL1322972 0.97 MDM2 (0.54) MDM2TP53ACHE
SCHEMBL1325239 0.82 MDM2 (0.51) MDM2TP53
SCHEMBL1320827 0.82 MDM2 (0.55) MDM2TP53ACHE
SCHEMBL1325985 0.81 MDM2 (0.55) MDM2TP53
SCHEMBL1319807 0.80 MDM2 (0.48) MDM2TP53MDM4
SCHEMBL1322315 0.80 MDM2 (0.50) MDM2TP53
SCHEMBL1319277 0.80 MDM2 (0.56) MDM2TP53ACHE
SCHEMBL3970399 0.79 MDM2 (0.51) MDM2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2066318-B1 OXINDOLE DERIVATIVES AS ANTICANCER AGENTS HOFFMANN LA ROCHE (CH) 2010-05-12 EP claimed
EP-2066318-A2 OXINDOLE DERIVATIVES AS ANTICANCER AGENTS F. Hoffmann-Roche AG (CH) 2009-06-10 EP claimed
WO-2008034736-A2 OXINDOLE DERIVATIVES AS ANTICANCER AGENTS F. HOFFMANN-LA ROCHE AG (CH) 2008-03-27 WO claimed
EP-2066318-B1 OXINDOLE DERIVATIVES AS ANTICANCER AGENTS HOFFMANN LA ROCHE (CH) 2010-05-12 EP disclosed
EP-2066318-A2 OXINDOLE DERIVATIVES AS ANTICANCER AGENTS F. Hoffmann-Roche AG (CH) 2009-06-10 EP disclosed
WO-2008034736-A2 OXINDOLE DERIVATIVES AS ANTICANCER AGENTS F. HOFFMANN-LA ROCHE AG (CH) 2008-03-27 WO disclosed